Low dose estradiol gender-affirming hormone therapy (GAHT) generates rapid feminizing body changes in transgender women: a dual energy x-ray absorptiometry-based prospective study | Synapse
May 6, 2024
Low dose estradiol gender-affirming hormone therapy (GAHT) generates rapid feminizing body changes in transgender women: a dual energy x-ray absorptiometry-based prospective study
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)